Sylvie Bodard Selected Research

N- (1- azabicyclo(2.2.2)oct- 3- yl)furo(2,3- c)pyridine- 5- carboxamide

6/2021	Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson's disease.
1/2018	Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1.
1/2015	Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvie Bodard Research Topics

Disease

9	Neuroinflammatory Diseases 06/2021 - 12/2008
8	Parkinson Disease (Parkinson's Disease) 06/2021 - 07/2007
4	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 11/2007
2	Gliosis 01/2014 - 02/2012
1	Neoplasms (Cancer) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Chorioamnionitis 11/2021
1	Brain Diseases (Brain Disorder) 11/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Huntington Disease (Huntington's Disease) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Leigh Disease (Leigh's Disease) 10/2016
1	Dyskinesias (Dyskinesia) 07/2013
1	Psychotic Disorders (Schizoaffective Disorder) 07/2013
1	Constipation 07/2013
1	Parkinsonian Disorders (Parkinsonism) 07/2013
1	T-Cell Leukemia (Leukemia, T Cell) 12/2010
1	Stroke (Strokes) 12/2010
1	Autistic Disorder (Autism) 02/2010
1	Brain Injuries (Brain Injury) 03/2006

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2007
4	Oxidopamine (6 Hydroxydopamine)IBA 06/2021 - 07/2012
4	Quinolinic AcidIBA 01/2021 - 01/2013
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 06/2021 - 01/2015
3	N- (1- azabicyclo(2.2.2)oct- 3- yl)furo(2,3- c)pyridine- 5- carboxamideIBA 06/2021 - 01/2015
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2016 - 07/2007
2	Neuroprotective AgentsIBA 06/2021 - 01/2018
2	LigandsIBA 02/2012 - 12/2008
2	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 12/2007 - 11/2007
1	Pharmaceutical PreparationsIBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	MelatoninIBA 11/2021
1	pyridineIBA 06/2021
1	Sigma-1 ReceptorIBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	BoronIBA 12/2019
1	EstersIBA 12/2019
1	Neuropeptide YIBA 10/2019
1	Heme Oxygenase-1IBA 01/2018
1	ElementsIBA 01/2018
1	CytokinesIBA 01/2016
1	PK 11195 (PK11195)IBA 01/2015
1	8- ((E)- 4- fluoro- but- 2- enyl)- 3beta- p- tolyl- 8- aza- bicyclo(3.2.1)octane- 2beta- carboxylic acid methyl esterIBA 01/2015
1	Nicotine FDA Link 01/2015
1	Levodopa (L Dopa)FDA LinkGeneric 07/2013
1	IronIBA 01/2013
1	Heme (Haem)IBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	Glycoproteins (Glycoprotein)IBA 12/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2010
1	Cholinergic Agents (Cholinergics)IBA 11/2007
1	benzovesamicolIBA 11/2007
1	Caspase 3 (Caspase-3)IBA 03/2006
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2006

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2008
1	Microbubbles 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Intraperitoneal Injections 01/2018
1	Transplantation 06/2008